← Back to directory

Jeffrey J. Raizer

Researcher Next ID · RN-020194

Researcher · Medicine

Northwestern University

Evanston, Philippines

Not currently recruitingFunding unknown
Works count
353
Citation count
13,508
H-index
54
i10-index
129

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Glioma Diagnosis and Treatment
Brain Metastases and Treatment
Meningioma and schwannoma management
Chromatin Remodeling and Cancer
Fibroblast Growth Factor Research

Publications

  • NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

    Journal of Clinical Oncology · 2022 · 10.1200/jco.22.00164

  • Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

    Nature Medicine · 2019 · https://doi.org/10.1038/s41591-019-0349-y

  • Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

    Neuro-Oncology · 2018 · 10.1093/neuonc/noy137

  • Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30517-x

  • Leptomeningeal metastases: a RANO proposal for response criteria

    Neuro-Oncology · 2016 · 10.1093/neuonc/now183

  • Central Nervous System Cancers, Version 1.2015

    Journal of the National Comprehensive Cancer Network · 2015 · 10.6004/jnccn.2015.0148

  • Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

    Neuro-Oncology · 2015 · 10.1093/neuonc/nou350

  • Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

    Neuro-Oncology · 2014 · 10.1093/neuonc/not330

  • Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

    Neuro-Oncology · 2014 · 10.1093/neuonc/nou089

  • A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma

    Clinical Cancer Research · 2013 · 10.1158/1078-0432.ccr-12-1707

  • Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Journal of Clinical Oncology · 2013 · 10.1200/jco.2013.50.4910

  • NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

    European Journal of Cancer · 2012 · https://doi.org/10.1016/j.ejca.2012.04.011

  • A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma

    Neuro-Oncology · 2011 · 10.1093/neuonc/noq198

  • A phase 2 trial of single‐agent bevacizumab given in an every‐3‐week schedule for patients with recurrent high‐grade gliomas

    Cancer · 2010 · 10.1002/cncr.25462

  • Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

    Journal of Neuro-Oncology · 2009 · 10.1007/s11060-009-9948-7

  • Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features

    Neuro-Oncology · 2008 · 10.1215/15228517-2007-058

  • Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

    Journal of Clinical Oncology · 2008 · 10.1200/jco.2008.16.7510

  • Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.12.5062

  • Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

    Clinical Cancer Research · 2006 · 10.1158/1078-0432.ccr-06-0773

  • Central Nervous System Cancers Clinical Practice Guidelines in Oncology

    Journal of the National Comprehensive Cancer Network · 2005 · 10.6004/jnccn.2005.0038

  • Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

    Investigational New Drugs · 2005 · 10.1007/s10637-005-1444-0

  • A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases

    Journal of Neuro-Oncology · 2001 · 10.1023/a:1012226718323

  • Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients

    Neurology · 2000 · 10.1212/wnl.54.6.1222

  • Single-Stage Posterolateral Transpedicle Approach for Spondylectomy, Epidural Decompression, and Circumferential Fusion of Spinal Metastases

    Spine · 2000 · 10.1097/00007632-200009010-00016

  • The Diagnosis and Treatment of Metastatic Spinal Tumor

    The Oncologist · 1999 · 10.1634/theoncologist.4-6-459

Current projects

    No projects listed.